NP39724 Generic and Biosimilar Cancer Medicines

Complete

Buyers

Value

£57,386,767

Classifications

  • Pharmaceutical products

Tags

  • tender

Submission Deadline

1 year ago

Published

1 year ago

Description

Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.

Similar Contracts

Open

LW158 IMP Support (FAME)

The purpose of this project is to appoint a supplier to handle the receipt of clinical trial Investigational Medicinal Product (IMP) from manufacturer, import, labelling, and distribution to the in-country sites/teams. The trial will be running in Cameroon and involves three oral drugs. Initial dose will be delivered to remote community clinic or healthcare facility and subsequent doses stored and given from the hospital site during the participant admission. For more information about this opportunity, please visit the Delta eSourcing portal at: https://www.delta-esourcing.com/tenders/UK-UK-Liverpool:-Pharmaceutical-products./93NSCJ7665 To respond to this opportunity, please click here: https://www.delta-esourcing.com/respond/93NSCJ7665

Katy Reed

Katy Reed

Published 3 days ago
Open

Combined Safety Needle & Syringes for vaccination administration

Procurement for combined needle and syringes required for the administration of a pandemic specific vaccine in the event of a pandemic.

Katy Reed

Katy Reed

Published 6 days ago
Open

Transitional Drugs 6

Supply of Apremilast; Denosumab; Pazopanib.

Katy Reed

Katy Reed

Published 2 weeks ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Body governed by public law

nadia Crockett

[email protected]

[email protected]

+44 1312252525

Timeline complete